🚨 Submit an abstract for #ERSCough2026 before the deadline (8 February)!
ℹ️ What will you gain from submitting?
💡 How will patients be involved?
Learn all this and more from organising committee member Dr Marta Dabrowska & submit before the deadline: https://t.co/qNDS5tcEiX
@EuroRespSoc We are proud to present the first ERS Monograph on Chronic cough. This focuses on emerging concepts in disease understanding and management. We thank you all for your interest and contributions!
📖 The forthcoming ERS Monograph on “Chronic Cough” is now available to pre-order. The book will cover pathophysiology, assessment, management, treatable traits & future directions.
Pre-order before 16 Nov & receive a €10 discount: https://t.co/w4ULNn34wD
ERJ Open Research: In this study, 1413 steps per day and 8 min of moderate-to-vigorous physical activity per day were proposed as the minimal clinically important differences in the physical activity in daily life in people with asthma https://t.co/k87zLch7qu
ERJOR: Among adults hospitalised with infection in rural Thailand, community-acquired pneumonia was associated with a distinct plasma metabolic profile compared with other infectious presentations and a four-metabolite signature predicted 28-day mortality https://t.co/6x2AxBCXqB
This classic article was the first to introduce one of the three key principles of evidence-based medicine: the somewhat ironic realization that #evidence itself can never guide clinical care. #Patient values & preferences must always play a key role. #EBM
https://t.co/VQ5LPlPa3V
This by far the best #SystematicReview of the long-term use of #opioids for chronic non-cancer #pain published in #JAMA demonstrates striking findings of their surprisingly small magnitude of effect.
https://t.co/6pliO0eirN
As previous post, #EBM has a breakthrough! #GRADE has become too complex and disorganized. Solution in 7 papers on GRADE essentials “Core GRADE” in #BMJ, introduced this week. Here link is to a two minute video summarizing the introductory paper.
https://t.co/4yPg2pXSRp
ERJ Open Res: Multimorbid severe COPD patients need to be treated with a complementary systemic approach. In this way, the patient, not only the airway disease, will be treated comprehensively, as two effects (metabolic and pulmonary) are better than one. https://t.co/IZTC2mDt6D
Gastroesophageal reflux #GERD is linked to #ChronicCough, but standard diagnostic tools have limitations. More research is needed to refine objective assessments for #reflux-related cough.
Editorial by Zhong et al. (2025) in @ERSpublications#OpenAccess - https://t.co/vOX4HSPM2y
Two weeks left to submit your abstract or clinical case and be part of the ERS Congress 2025 in Amsterdam.
Don’t miss your chance to be part of the programme!
Learn more and submit: https://t.co/3zbHVfp1NR
Deeply honoured to be designated as an ATS Fellow by @atscommunity. I want to thank my mentors, colleagues and friends for this recognition.
@ATS_Assemblies@ATS_PITB
https://t.co/dxxVdPLZyZ
📣Hot off the press! 👇
Read about the effects of eHealth exercise programmes in children and adolescents with chronic suppurative lung diseases (mostly cystic fibrosis)
Aspasia Mavronasou, @kortianou and team 👏
https://t.co/PcxeOHQFDh
CANVAS/RFC1 disorders are an important cause of chronic cough. Here, a prevalence of 8% in patients is reported with refractory chronic cough. In RFC1 disorders, there is cough reflex hypersensitivity, impaired nerve conduction and neurological symptoms. https://t.co/2AqYIqzJd6
• ciTechCare DEDICATES A SESSION ON MANAGEMENT OF RESPIRATORY DISEASE AND COUGH •
On Jan 17, two distinguished researchers from the respiratory area will promote the "New Perspectives in the Management of Respiratory Disease and Cough" session.
Join us! https://t.co/Qe2r1hhjvw.
ERJOR: This nationwide real-world study uses high-resolution data to document that elexacaftor/tezacaftor/ivacaftor halts progression of lung disease in cystic fibrosis, and improves lung function across all ages, disease severities and prior modulator use https://t.co/Y5g00tYKh0